Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Curis stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRIS.
You can purchase shares of Curis (NASDAQ:CRIS) through any online brokerage.
Other companies in Curis’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Nanoviricides (AMEX:NNVC), Can Fite Biofarma (AMEX:CANF), Bolt Biotherapeutics (NASDAQ:BOLT) and GlycoMimetics (NASDAQ:GLYC).
Curis has a consensus price target of $15.00.
The stock price for Curis (NASDAQ: CRIS) is $1.71 last updated April 25, 2025 at 7:42 PM EDT.
There are no upcoming dividends for Curis.
Curis’s Q1 earnings are confirmed for Friday, May 9, 2025.
There is no upcoming split for Curis.
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.